Search
for
Sort by
Research 91–120 of 342
- <i>Polycystic Ovary Syndrome in Adolescence</i>
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- Infertility in Polycystic Ovary Syndrome: Focus on Low-Dose Gonadotropin Treatment
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- Fadrozole and finasteride exposures modulate sex steroid- and thyroid hormone-related gene expression in Silurana (Xenopus) tropicalis early larval development
- The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research
- Elevated Free Testosterone Levels in Women With Acne
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Therapeutic approach for metabolic disorders and infertility in women with PCOS
- 46,XY DSD due to impaired androgen production
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- Kisspeptin and LH pulsatile temporal coupling in PCOS patients
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission
- Evidence-based approach to cutaneous hyperandrogenism in women
- Platelet-Rich Plasma as a Treatment for Androgenetic Alopecia
- Dermatoses of pregnancy
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Management of CAH during pregnancy
- A missing piece: the spiny mouse and the puzzle of menstruating species
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Selenium and Polycystic Ovary Syndrome; Current Knowledge and Future Directions: A Systematic Review
- Managing polycystic ovary syndrome in primary care